WORCESTER, Mass., Oct. 31, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will hold a conference call for the investment community on Thursday, November 1, 2007 at 11 a.m. eastern time.
